2-hydroxypropyl-b-cyclodextrin: Phase I started

NIH said its National Center for Advancing Translational Sciences (NCATS) and the Eunice Kennedy Shriver

Read the full 151 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE